AI summary · DOI: 10.64898/2026.11.10.26367605 · medRxiv: Cardiovascular Medicine

Nationwide Functional Profiling Enables Clinical Reclassification of KCNH2 Variants in the French LQT2 Population

B. Ribeiro de Oliveira, M. Alameh, S. Feliciangeli, J. Montnach, B. Quemeneur, T. Gabillon, N. Aoujaj, A. Rio,
and 15 more authorsF. Bibault, E. Lecointe, N. Ba, E. Voisin, I. Baro, R. Redon, A. Thollet, J.-J. Schott, A. Gaignard, I. Denjoy, V. Probst, R. Majumder, F. Lesage, G. Loussouarn, M. De Waard
Original paper Published on 12 Nov. 2026 medRxiv preprint License: CC BY 4.0 Also in: fr

How to read this summary? Illustrated guide

The essentials

Standardized functional profiling of 303 French KCNH2 variants integrated with MeTAL modeling and calibrated ACMG evidence to reclassify 64 VUS.

Question

Can nationwide, standardized functional testing and computational modeling clarify the clinical significance of KCNH2 variants, particularly variants of uncertain significance (VUS)? How can the resulting functional evidence be calibrated and incorporated into clinical variant classification?

Method

The researchers functionally characterized 303 KCNH2 variants from a French national registry, including 201 VUS, using automated patch-clamp recordings; a subset of 73 variants also underwent trafficking assays. They integrated nine electrophysiological parameters with MeTAL modeling, assessed 187 variants under balanced heterozygous conditions, compared predictions with available clinical data, and calibrated functional evidence against 20 benign/likely benign and 38 pathogenic reference variants before ACMG/AMP reclassification.

Findings

  • Result Current amplitude alone missed substantial dysfunction: among 89 variants with less than a 30% current reduction, 35 were predicted to have severe channel dysfunction.
    See the passage in the paper
    Among the 89 variants whose square-root-transformed current amplitude (% of WT) remained above −22.7%, corresponding to a reduction of less than 30% in normalized current amplitude, 35 (39.3%) nonetheless exhibited severe channel dysfunction.
  • Result MeTAL classified 111 of the 201 VUS as dysfunctional under homozygous conditions, and 187 variants in total were selected for heterozygous testing.
    See the passage in the paper
    Among the 201 VUS, MeTAL classified 111 as producing dysfunctional hERG channels (55.2%), warranting further investigation under heterozygous conditions.
  • Result The continuous likelihood-ratio calibration distinguished functional evidence strength and had an AUC of 0.936 for discriminating benign/likely benign from pathogenic reference variants.
    See the passage in the paper
    MeTAL-modeled QTc showed high discriminatory performance between B/LB and pathogenic reference variants, with an area under the ROC curve of 0.936 (Figure 5e).
  • Result Continuous likelihood-ratio calibration reclassified 64 of 201 VUS: seven as pathogenic, 46 as likely pathogenic, and 11 as likely benign.
    See the passage in the paper
    This approach enabled the reclassification of 64 of the 201 VUS (31.8%), including seven as pathogenic, 46 as likely pathogenic, and 11 as likely benign.
  • Authors’ interpretation The authors argue that combining multidimensional electrophysiology, MeTAL modeling, calibrated evidence, and clinical context provides a scalable framework for interpreting KCNH2 variants.
    See the passage in the paper
    Together, our findings establish a scalable framework in which standardized multidimensional electrophysiology defines channel dysfunction and MeTAL translates this dysfunction into a clinically interpretable repolarization phenotype.

Limitations

  • The expression system does not reproduce the full human cardiomyocyte environment or all aspects of endogenous allele-specific expression and regulation.
    See the passage in the paper
    The expression system, although standardized and highly scalable, does not reproduce the molecular and electrophysiological environment of human cardiomyocytes, and the controlled WT/variant context used to model heterozygosity may not reproduce all aspects of endogenous allele-specific expression, subunit assembly or cellular regulation.
  • MeTAL is an intermediate model and cannot capture every interaction among cardiac ionic currents.
    See the passage in the paper
    MeTAL is an intermediate computational representation of ventricular repolarization and pseudo-ECG modelling rather than a complete model of ventricular repolarization, and therefore cannot capture all interactions among cardiac ionic currents.
  • The classifications were not comprehensive de novo ACMG/AMP assessments because non-functional criteria were retained from prior evaluations rather than reassessed.

Why it matters

The authors present a national-scale workflow that connects standardized, multiparametric functional measurements to clinically interpretable QT phenotypes and calibrated ACMG/AMP evidence. They argue that this approach can improve VUS interpretation and support diagnosis and risk stratification, while the open database enables access to the variant-level data.

Written by AI from the paper. Passages are checked word for word against the text we analysed; the rest may contain errors.

AI-generated keywords: KCNH2; long QT syndrome type 2; variants of uncertain significance; functional assay; variant classification

Read further

  • Comprehensive Summary
  • Layman's Summary
  • Blog article
  • Original abstract
The study addresses a key challenge in inherited long QT syndrome type 2 (LQT2): many variants in *KCNH2*, the gene encoding the hERG cardiac potassium channel, remain variants of uncertain significance (VUS). This uncertainty complicates clinical interpretation and family risk assessment. The authors aimed to measure the functional effects of variants identified in France, estimate their effects on cardiac repolarization, and determine whether calibrated functional evidence could support clinical reclassification. Using records from the French Cardiogen network, the researchers selected 303 variants: 201 VUS, 21 benign or likely benign variants, and 81 pathogenic or likely pathogenic variants. They measured channel activity in HEK-293T cells using a standardized automated patch-clamp assay. The analysis included current amplitude and channel properties such as activation, inactivation, and gating kinetics. For 73 variants, the team also assessed membrane trafficking. Experiments used both variant-only expression and balanced co-expression of wild-type and variant channels to approximate the heterozygous state found in patients. The computational framework MeTAL integrated nine functional parameters to predict QT intervals. The team compared these predictions with available patient ECGs and calibrated functional results against established benign and pathogenic variants under ClinGen guidance. They then incorporated the resulting evidence into an ACMG/AMP point-based classification framework. Current amplitude alone did not capture the full range of channel dysfunction. Of the 201 VUS, 53 had abnormal current-amplitude scores, while some established pathogenic variants had apparently normal amplitudes. Among the 73 variants tested for trafficking, 55 of the 63 with reduced current also showed impaired membrane trafficking. This suggests that trafficking defects explain much, but not all, of the loss of function. Under variant-only conditions, MeTAL identified 187 of the 303 variants as functionally abnormal, including 111 VUS. It also predicted abnormal QT intervals for 35 of 89 variants whose current amplitude alone did not indicate sufficient dysfunction. Under heterozygous conditions, MeTAL classified 63 of 111 tested VUS as having short- or long-QT-like functional phenotypes. Among patients with available data, predictions agreed with clinical QTc phenotypes in 82.9% of observations for pathogenic variants, 76.2% for likely pathogenic variants, and 45.5% for VUS. The lower agreement for VUS is consistent with greater uncertainty and variable penetrance. The researchers calibrated functional evidence using two approaches. The categorical approach assigned moderate evidence toward pathogenicity or benignity. The continuous likelihood-ratio approach graded the strength of evidence and achieved an area under the ROC curve of 0.936 when distinguishing reference pathogenic variants from benign ones. With the categorical approach, 58 of the 201 VUS were reclassified as likely pathogenic. The continuous approach reclassified 64: seven as pathogenic, 46 as likely pathogenic, and 11 as likely benign. These classifications combined new functional evidence with previously available evidence; they were not de novo assessments of every ACMG criterion. The study’s strengths include its national-scale variant set, standardized functional testing, explicit evidence calibration, and open database, HAMMER, which brings together functional, computational, and available clinical information. Its limitations include the use of cell systems rather than human cardiomyocytes and reliance on MeTAL, a computational model that does not fully represent human cardiac electrophysiology. Clinical QTc can also be influenced by factors beyond the variant, so functional evidence does not replace comprehensive clinical evaluation. Overall, the findings support using integrated, calibrated functional data to help interpret *KCNH2* variants. These predictions should be considered alongside patient phenotypes, penetrance, and other genetic evidence.

Was this synthesis useful?

Score: 0

Why do we need votes?

Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.

Ask questions about this paper to our AI assistant

How to chat with this paper? Illustrated guide

You can also chat with multiple papers at once here.

Figures and plots

Ask about a figure by number or use its question button to request visual analysis. Up to two figures and four image panels per question. Values read from plots are approximate; check the original data.

AI assistant instructions?

Tools for this paper

Explain it differently 1 free rewrite left today
Save to a collection Group papers in collections to compare them, chat with them and export them. Continue with Google Create a free account Log in

Advanced tools Premium

For researchers who follow a field closely: citation alerts, journal-club slides, version comparison and Zotero export. Discover Premium

Zotero Zotero guide
Citation alerts Citation alerts guide
Who works on it?

Among the 15 papers around this one, the name that comes back most: A. Bakalakos (2 papers)

Continue with Google Create a free account: your first map is free
Weekly letter Presented in "Biology and medicine this week" of 16 November 2026. Biology and medicine this week: New jobs for cells, enzymes and genes · Receive one by email for free

Papers around this one

See them on a map

Ranked by how close their title and abstract are to this paper’s. Select some to read them together.

Closest papers

  1. Very close Same question
    Multimodal KCNQ1 Variant-Effect Maps Define Ion Channel Mechanisms and Disease Risk
    M. L. Harvey, E. Osborn, M. Lancaster et al. · 2026 · Circulation · cited 1 time · Not summarized yet

    Multimodal KCNQ1 Variant-Effect Maps characterizes KCNQ1 variants to clarify long-QT syndrome risk and interpret variants of uncertain significance.

    Abstract

    Background: Variants in the ion channel gene KCNQ1 are the leading cause of congenital Long QT Syndrome (LQTS), a disorder characterized by QT prolongation and risk of fatal arrhythmias. The expanding use of genetic testing has led to the identification of numerous variants of uncertain significance (VUS), complicating clinical interpretation and risk stratification. Functional characterization of KCNQ1 variants is essential to define their role in LQTS and advance precision medicine in cardiovascular care. Methods: We generated a nearly comprehensive variant library of 13,403 protein-coding variants in KCNQ1. Using 4 pooled assays followed by high-throughput sequencing, we characterized the…

  2. Very close Same method, another problem
    Likelihood ratio calibration aligns MAVE and automated patch-clamp functional evidence for KCNH2 variants in long QT syndrome.
    Q. Shen, Joanne G. Ma, Brett M. Kroncke et al. · 2026 · Heart Rhythm · Not summarized yet

    Likelihood ratio calibration compares KCNH2 surface-trafficking and automated patch-clamp evidence, calibrating functional results for clinical interpretation.

    Abstract

    BACKGROUND Many people with long QT syndrome carry missense variants that are classified as variants of uncertain significance. Functional evidence from laboratory experiments can help improve genetic diagnosis, but it requires proper validation before use in a clinical interpretation framework. OBJECTIVE To compare two functional datasets for KCNH2 variants: a high-throughput assay that measures how much KV11.1 channel reaches the cell surface, and automated patch clamp, which measures the level of potassium current in HEK293 cells. METHODS Automated patch clamp results were converted into likelihood ratios using reference sets of pathogenic and benign KCNH2 variants. These values were then…

  3. Very close Broader context
    Expression-System Biases Compromise the Functional Assessment of KCNH2 Variants and Clinical Risk Assessment
    Aline Rio, Malak Alameh, S. Feliciangeli et al. · 2026 · bioRxiv · preprint, not peer reviewed · Not summarized yet

    Expression-System Biases tests how wild-type-to-variant expression ratios affect KCNH2 functional measurements and risk assessment in heterozygous patients.

    Abstract

    Background Functional characterization of KCNH2 variants is essential for assessing pathogenicity in long QT syndrome type 2. Because hERG channels assemble as tetramers, the relative expression of wild-type (WT) and variant subunits critically influences channel function and pathogenicity assessment. However, commonly used experimental systems may not reproduce the balanced allelic expression observed in heterozygous patients. Methods Allele-specific KCNH2 expression was analyzed in two independent RNA-sequencing datasets from human left ventricular tissue. Using the dominant-negative T74R hERG variant as a model, we calibrated the relationship between WT-to-variant expression ratios and hE…

  4. Close Broader context
    Convergent genetic and functional evidence implicate KCND3 in Brugada Syndrome
    H. Liu, A. Verkerk, P. Lindenbaum et al. · 2026 · medRxiv · preprint, not peer reviewed · Not summarized yet

    Convergent genetic and functional evidence studies rare KCND3 variants and channel dysfunction in Brugada syndrome using patient genetics and patch clamp.

    Abstract

    Background: Dysfunction of the KCND3-encoded Kv4.3 channel, which carries the transient outward potassium current (Ito), has long been suspected to contribute to the pathophysiology of Brugada Syndrome (BrS). Although recent genome-wide association studies (GWAS) have implicated KCND3, the role of rare variation in this gene remains uncertain and clinically unactionable. Methods: Genome sequencing was performed in 983 BrS probands from Europe and Thailand. Putative gain-of-function (GoF) rare variants in KCND3 identified in patients were functionally characterized by patch-clamp analysis of Kv4.3 current properties using a HEK293 cell heterozygous model. Biobank datasets were utilized to eva…

  5. Close Broader context
    Systematic Reclassification of Variants of Uncertain Significance in a Clinical Nephrogenomics Program: Insights from the RAPIDS Collaboration
    Tung-Lin Lee, Yao-Chun Zhang, Tina Si Ting Lim et al. · 2026 · Clinical Kidney Journal · Not summarized yet

    Systematic Reclassification applies a clinical framework to reclassify nephrogenomics VUS, addressing variant interpretation in a different disease area.

    Abstract

    A nationwide nephrologist-led genetic testing program for suspected monogenic glomerular disease and unexplained chronic kidney disease was implemented across four tertiary hospitals in Singapore. Initial testing yielded a genetic diagnosis in 11.5% probands, while 77 (18.4%) harboured variants of uncertain significance (VUS) that could explain their kidney disease (VUS-congruent). We evaluated a structured pipeline for reclassifying VUS-congruent to likely pathogenic or pathogenic (LP/P) to improve diagnostic yield and clinical utility. Probands with VUS-congruent were reviewed at monthly multidisciplinary genomic board meetings. A stepwise framework incorporated genotype–phenotype correlat…

  6. Close Same method, another problem
    Functional analysis enables reclassification of SCN1A missense variants of uncertain significance in epilepsy
    K. Pilli, T. Allan, M. F. Bennett et al. · 2026 · medRxiv · preprint, not peer reviewed · Not summarized yet

    Functional analysis enables reclassification tests SCN1A missense variants with functional evidence to support ACMG-based classification in epilepsy.

    Abstract

    SCN1A, the most prominent gene for epilepsy, encodes the pore-forming subunit of the voltage-gated sodium channel, NaV1.1. Loss-of-function variants reduce NaV1.1 activity in inhibitory neurons leading to hyperexcitability; they are associated with a spectrum of epilepsies, from self-limited phenotypes in genetic epilepsy with febrile seizures plus, to the prototypic developmental and epileptic encephalopathy, Dravet syndrome. Thousands of SCN1A missense variants have been identified, but determining pathogenicity using ACMG criteria can be challenging. Currently, 48% of missense SCN1A variants in ClinVar are classified as variants of uncertain significance (VUS). We aimed to provide functio…

  7. Close Same method, another problem
    A benign control-calibrated multiparametric functional assay supports CACNA1A variant assessment
    C.-Y. Tan, N. Maksemous, J.-G. Ma et al. · 2026 · medRxiv · preprint, not peer reviewed · Not summarized yet

    A benign control-calibrated multiparametric functional assay develops calibrated automated patch-clamp evidence to assess CACNA1A variants.

    Abstract

    CACNA1A-related disorders arise from altered function of the P/Q-type calcium channel Cav2.1 and encompass a broad spectrum of neurological phenotypes, including developmental and epileptic encephalopathy, familial hemiplegic migraine type 1 and episodic ataxia type 2. Although loss-of-function and gain-of-function mechanisms have both been implicated, interpretation of rare CACNA1A missense variants remains challenging because clinical presentation is heterogeneous and many variants identified through diagnostic sequencing remain classified as variants of uncertain significance. To generate clinically interpretable functional evidence, we developed a calibrated high-throughput automated pat…

  8. Close Broader context
    Genotype-phenotype correlations in KCNA2 related neurodevelopmental disorder: expanding the clinical and molecular spectrum.
    Ji-Yuan Zhang, Song Su, Wan-Dong Hu et al. · 2026 · Seizure · Not summarized yet

    The study analyzes KCNA2 variant effects and genotype–phenotype relationships in neurodevelopmental disorder, not KCNH2 variant classification in LQT2.

    Abstract

    BACKGROUND Pathogenic variants in KCNA2 are associated with developmental and epileptic encephalopathy 32 (DEE32), but genotype-phenotype correlations remain unclear. METHODS Whole-exome sequencing was performed in patients with developmental delay and/or epilepsy. Previously reported KCNA2 variants were reviewed to assess pathogenicity and genotype-phenotype associations. Structural modeling, in silico prediction, and spatiotemporal expression analyses were conducted to evaluate the potential effects of variants. RESULTS Four patients from unrelated families were identified with KCNA2 missense variants, including two novel variants, c.749T>G (p.Phe250Cys) and c.986G>A (p.Gly329Asp), and the…

How are these papers found?

We compare the title and abstract of this paper with those of every paper summarized on this site, and with the papers Semantic Scholar recommends, those it cites and those citing it (for a much-cited paper, its most recent citations and, from OpenAlex, the most cited ones). Among the prior work and the follow-ups, the papers that use each other in depth, a method it uses and the much-cited follow-ups come a little higher. The levels (very close, close, related) come from the similarity of the texts, not from a judgment of quality; * marks a paper without an abstract, compared by its title. The sentence under a paper is written by an AI from the two abstracts: check it in the papers. A paper marked not relevant by three readers leaves the list.

Updated on 16 November 2026.

The illustrated guide to the papers around a paper

Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.